Skip to main content
METabolic EXplorer logo

METabolic EXplorer — Investor Relations & Filings

Ticker · METEX ISIN · FR0004177046 LEI · 969500VI1GSBPGD9B460 PA Manufacturing
Open in API
Filings indexed 524 across all filing types
Latest filing 2015-11-13 Interim / Quarterly Rep…
Country FR France
Listing PA METEX

About METabolic EXplorer

https://www.metabolic-explorer.com/

METabolic EXplorer (METEX) is an industrial biotechnology company specializing in the development and industrialization of fermentation bioprocesses. The company produces functional ingredients and chemical intermediates from renewable, non-food raw materials, offering sustainable alternatives to petrochemical processes. Its portfolio is centered on three main product families: 1,3-propanediol (PDO) for cosmetics, liquid polymers, and textiles; butyric acid (BA) for animal nutrition and the flavors and fragrances market; and amino acids for animal feed. The company operates through its subsidiaries, METEX NØØVISTA, which manages the PDO and BA production, and METEX NØØVISTAGO, which focuses on amino acids and ingredients for animal nutrition.

Recent filings

Filing Released Lang Actions
Information financière du 3ème trimestre 2015
Interim / Quarterly Report Classification · 95% confidence The document is a quarterly financial update from METabolic EXplorer for the third quarter of 2015. It provides specific financial data, including revenue figures and cash position (treasury) as of September 30, 2015, presented in a table and narrative format. While it is relatively short, it contains substantive financial data rather than just announcing the availability of a report, thus qualifying it as an Interim/Quarterly Report (IR) rather than a Report Publication Announcement (RPA). Q3 2015
2015-11-13 French
SK Chemicals a notifié à METabolic EXplorer sa décision de mettre fin à l'accord de licence
Legal Proceedings Report Classification · 99% confidence The document is a press release dated November 9, 2015, announcing that SK Chemicals has terminated a license agreement with METabolic EXplorer regarding the PDO technology. This announcement details a significant business event—the termination of a major partnership and the recovery of technology rights. This type of corporate action announcement, which is not a standard periodic financial report (like 10-K or IR), nor a management change (MANG), nor a dividend notice (DIV), nor a transaction in own shares (POS), best fits the category for general corporate news or regulatory updates that don't fit elsewhere. Since it is a specific announcement about a major business development (licensing termination), it is most appropriately classified as a general Regulatory Filing (RNS) as it is a material event disclosure, or potentially a Legal/Contractual update, but RNS serves as the best general regulatory announcement fallback for non-standard material news.
2015-11-09 French
Déclaration du nombre total de Droits de Vote et d'Actions composant le capital social
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is titled "Déclaration du nombre total de Droits de Vote et d'Actions composant le capital social" (Declaration of the total number of Voting Rights and Shares comprising the share capital) and is dated as of 31/10/2015. It explicitly lists the total number of shares and theoretical voting rights, and then calculates the exercisable voting rights after accounting for treasury shares. This content directly relates to the official declaration of voting rights and share structure, which aligns perfectly with the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA). The document is short and contains the final figures, not an announcement about a future vote result.
2015-11-05 French
Déclaration du nombre total de Droits de Vote et d'Actions composant le capital social
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document is titled "Déclaration du nombre total de Droits de Vote et d'Actions composant le capital social" (Declaration of the total number of Voting Rights and Shares comprising the share capital) and is dated as of 30/09/2015. It explicitly lists the total number of shares and theoretical voting rights, and then details shares deprived of voting rights (autodétention). This content directly relates to the official count of voting rights and shares, which aligns perfectly with the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). It is not an AGM presentation, a full annual report, or a simple dividend notice.
2015-10-07 French
Déclaration du nombre total de Droits de Vote et d'Actions composant le capital social
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document is titled "Déclaration du nombre total de Droits de Vote et d'Actions composant le capital social" (Declaration of the total number of Voting Rights and Shares comprising the share capital) and provides updated figures for two specific dates (31/07/2015 and 31/08/2015) regarding the total number of shares and theoretical/exercisable voting rights. This content directly relates to the official declaration of voting rights and share structure, which aligns precisely with the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA). It is not an AGM presentation, a full annual report, or a simple dividend notice.
2015-09-11 French
BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE CONTRACTE AVEC CM-CIC Securities
Capital/Financing Update Classification · 99% confidence The document is very short (649 characters) and appears to be a formal, periodic update regarding a liquidity contract ('contrat de liquidité') between the company (METABOLIC EXPLORER) and a financial intermediary (CM-CIC Securities). It details the holdings (shares and cash) in the liquidity account as of June 30, 2015, comparing it to the previous period (December 31, 2014). This type of regular, specific financial arrangement update, which is not a full financial report (10-K, IR) or a general earnings release (ER), fits best under the category for specific financial updates or regulatory notices. Given the options, 'Capital/Financing Update' (CAP) covers financing activities, and 'Regulatory Filings' (RNS) is a fallback. However, since this is a specific report on a liquidity agreement, which is a form of capital management/market support, 'CAP' is a strong candidate. Alternatively, if this is a required periodic disclosure that doesn't fit elsewhere, 'RNS' applies. Given the nature of a 'Bilan Semestriel' (Half-Year Balance/Report) on a liquidity contract, it is a specific financial disclosure. Since there is no explicit 'Liquidity Report' code, and it is a formal, periodic disclosure, 'RNS' (Regulatory Filings/General Announcement) is the most appropriate general classification for a specific, non-core financial statement filing that isn't a standard quarterly/annual report or an earnings release.
2015-07-08 French

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.